Search - tctmd.com

Displaying 1 - 20 of 398

Sort: Relevancy | Date

News Daily News

Fish Oil Halves CV Risk in Patients on Dialysis: PISCES

Yael L. Maxwell

November 10, 2025

News Daily News

Oral Semaglutide Gets FDA Approval for CV Event Reduction in High-risk Diabetes Patients

Caitlin E. Cox

October 22, 2025

News Daily News

ACC: It’s Time for Clinicians to Address Inflammation in CVD

Caitlin E. Cox

October 03, 2025

News Daily News

Inclisiran Gains Indication as Stand-alone Therapy to Reduce LDL Cholesterol

Michael O'Riordan

August 06, 2025

News Daily News

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

L.A. McKeown

July 24, 2025

News Daily News

AI Has Great Potential in CV Pharmacotherapy, but Much Work Lies Ahead: Review

Todd Neale

July 24, 2025

News Daily News

GLP-1s May Stave Off Dementia, EHR-Based Study Shows

Caitlin E. Cox

July 21, 2025

News Daily News

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

L.A. McKeown

July 15, 2025

News Daily News

Catheter Ablation for AF: Fewer Strokes, Deaths, and HF Hospitalizations

L.A. McKeown

July 08, 2025

News Daily News

Weight-Loss Medications Should Be Part of Cardiology’s Arsenal: ACC

Michael O'Riordan

June 25, 2025

News Daily News

Amylin Analogue Boosts Weight Loss When Added to GLP-1

L.A. McKeown

June 24, 2025

News Daily News

PREVENT Risk Calculator Works Well in Patients With High and Low Lp(a)

Michael O'Riordan

June 10, 2025

News Daily News

Eye Condition a ‘Very Rare’ Side Effect of Semaglutide, EMA Says

Todd Neale

June 06, 2025

News Daily News

Inclisiran Effective as Monotherapy for Lower-Risk Primary Prevention

Michael O'Riordan

May 07, 2025

News Daily News

Lp(a) Genetics Differ Between Populations but Have Similar Clinical Impact

Yael L. Maxwell

May 05, 2025

News Daily News

HDL Cholesterol Levels May Sway Statin Decisions in Primary Prevention

Michael O'Riordan

May 02, 2025

News Daily News

Funding for Women’s Health Initiative Imperiled, but Appears Secure for Now

Yael L. Maxwell

April 25, 2025

News Daily News

Knowledge of Genetic Risk for CAD Bolsters Prevention, Reduces MACE

Caitlin E. Cox

April 23, 2025

News Daily News

Risk of Another Event Remains High for Years After TIA, Minor Stroke

Todd Neale

March 26, 2025

Advertisement

Fish Oil Halves CV Risk in Patients on Dialysis: PISCES

Oral Semaglutide Gets FDA Approval for CV Event Reduction in High-risk Diabetes Patients

ACC: It’s Time for Clinicians to Address Inflammation in CVD

Inclisiran Gains Indication as Stand-alone Therapy to Reduce LDL Cholesterol

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

AI Has Great Potential in CV Pharmacotherapy, but Much Work Lies Ahead: Review

GLP-1s May Stave Off Dementia, EHR-Based Study Shows

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

Catheter Ablation for AF: Fewer Strokes, Deaths, and HF Hospitalizations

Weight-Loss Medications Should Be Part of Cardiology’s Arsenal: ACC

Amylin Analogue Boosts Weight Loss When Added to GLP-1

PREVENT Risk Calculator Works Well in Patients With High and Low Lp(a)

Eye Condition a ‘Very Rare’ Side Effect of Semaglutide, EMA Says

Inclisiran Effective as Monotherapy for Lower-Risk Primary Prevention

Lp(a) Genetics Differ Between Populations but Have Similar Clinical Impact

HDL Cholesterol Levels May Sway Statin Decisions in Primary Prevention

Funding for Women’s Health Initiative Imperiled, but Appears Secure for Now

Knowledge of Genetic Risk for CAD Bolsters Prevention, Reduces MACE

Risk of Another Event Remains High for Years After TIA, Minor Stroke

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content